Home › Funds › Monaco Asset Management SAM › MRVI

Monaco Asset Management SAM position in MRVI

MARAVAI LIFESCIENCES HLDGS I · Health Care

Monaco Asset Management SAM reported holding 647,000 shares of MRVI (MARAVAI LIFESCIENCES HLDGS I) in its Q3 2026 13F filing — a position valued at US$5.0M, representing 0.71% of its reported portfolio and ranking #21 among its reported holdings. Monaco Asset Management SAM has disclosed MRVI holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)647.00K sh
Reported value held$4.96M
Portfolio Weight0.71%
First reportedQ4 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Monaco Asset Management SAM's MRVI position evolved

Monaco Asset Management SAM first disclosed a stake in MRVI in Q4 2023 at 311,210 shares (US$2.0M). The position peaked in Q2 2026 at 2,231,026 shares, worth US$13.9M. Across 12 filings, Monaco Asset Management SAM increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 647,000 shares valued at US$5.0M — a reduction of -1,584,026 shares quarter over quarter.. Notable position changes include a 288% increase in Q4 2024 (shares fell 59% over the following quarter), a 187% increase in Q1 2025 (shares rose 9% over the following quarter), a 315% increase in Q3 2025 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 311.21K $2.04M New
Q1 2024 158.15K $1.37M Reduce
Q2 2024 200.00K $1.43M Add
Q3 2024 75.00K $623.25K Reduce
Q4 2024 291.36K $1.59M Add
Q1 2025 835.87K $1.85M Add
Q2 2025 880.97K $2.12M Add
Q3 2025 3.66M $10.49M Add
Q4 2025 3.46M $11.25M Reduce
Q1 2026 3.42M $9.68M Reduce
Q2 2026 2.23M $13.92M Reduce
Q3 2026 647.00K $4.96M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRVI and 13F data

MRVI (MARAVAI LIFESCIENCES HLDGS I) is a Health Care company. 36 other funds we track also report a position in MRVI — the largest reported positions include GTCR LLC (US$125.7M), BRAIDWELL LP (US$54.3M), 12 West Capital Management LP (US$44.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRVI

All MRVI fund holders →

FAQ

How long has Monaco Asset Management SAM held MRVI?

Monaco Asset Management SAM has disclosed MRVI holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is Monaco Asset Management SAM's current position in MRVI?

As of Q3 2026, Monaco Asset Management SAM holds 647.00K shares of MRVI (MARAVAI LIFESCIENCES HLDGS I), valued at $4.96M, representing 0.71% of its reported portfolio and ranking #21.

Has Monaco Asset Management SAM been buying or selling MRVI?

In the latest 13F filing (Q3 2026), Monaco Asset Management SAM reduced its position in MRVI. The position peaked in Q2 2026 at 2.23M shares.

Which other funds hold MRVI?

Other major institutional holders of MRVI include GTCR LLC, BRAIDWELL LP, 12 West Capital Management LP, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.